Innoviva Inc. Stock
Innoviva Inc. Stock
There is no change in the price for Innoviva Inc. today.
Innoviva Inc. is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
As a result the target price of 28 € shows a very positive potential of 50.54% compared to the current price of 18.6 € for Innoviva Inc..
Pros and Cons of Innoviva Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innoviva Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innoviva Inc. | 0.000% | -3.175% | -7.107% | 17.308% | 11.585% | 81.188% | 81.188% |
| Rockwell Medical Inc. | 0.230% | 4.218% | 8.876% | -33.032% | 26.016% | -28.361% | -93.018% |
| Pacira Pharmaceuticals | 0.520% | -3.571% | -3.077% | -11.682% | -12.500% | -47.207% | -67.130% |
| Twist Bioscience Corp | -0.760% | -2.122% | -6.060% | -3.406% | 37.487% | 159.946% | -65.505% |
Comments
Innoviva (INVA) had its "buy" rating reaffirmed by BTIG Research. They now have a $35.00 price target on the stock.
Show more
Ratings data for INVA provided by MarketBeat
Innoviva (NASDAQ:INVA) had its price target raised by analysts at HC Wainwright from $45.00 to $46.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INVA provided by MarketBeat
Innoviva (NASDAQ:INVA) had its price target raised by analysts at Cantor Fitzgerald from $29.00 to $31.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for INVA provided by MarketBeat
News
Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out
Biotech companies provide the medical innovations and technological breakthroughs that improve healthcare and can achieve tremendous financial results in the process. However, these names also
